SNTI
Senti Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.33
−2.49%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-65.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Mar 11, 2026 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | F-InKind | 10,757 | $0.00 |
| Mar 11, 2026 | Lu Timothy K · director, officer: CEO | F-InKind | 80,666 | $0.00 |
| Feb 3, 2026 | Lu Timothy K · director, officer: CEO | F-InKind | 4,191 | $0.00 |
| Feb 3, 2026 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | F-InKind | 1,384 | $0.00 |
| Jul 21, 2025 | Baum Bryan Daniel · director | A-Award | 43,900 | $1.95 |
| Jun 27, 2025 | COOPERSTONE BRENDA · director | A-Award | 21,950 | $2.05 |
| Jun 27, 2025 | Tang Donald F · director | A-Award | 21,950 | $2.05 |
| Jun 27, 2025 | Mathers Edward T · director | A-Award | 21,950 | $2.05 |
| Jun 27, 2025 | Collins James J. · director | A-Award | 21,950 | $2.05 |
| Jun 27, 2025 | Hsiung Feng · director | A-Award | 21,950 | $2.05 |
| Jun 27, 2025 | Schulz Fran · director | A-Award | 21,950 | $2.05 |
| Mar 11, 2025 | Collins James J. · director | A-Award | 43,900 | $3.52 |
| Mar 11, 2025 | Tang Donald F · director | A-Award | 43,900 | $3.52 |
| Mar 11, 2025 | COOPERSTONE BRENDA · director | A-Award | 43,900 | $3.52 |
| Mar 11, 2025 | Hsiung Feng · director | A-Award | 43,900 | $3.52 |
| Mar 11, 2025 | Cross John Harry III · officer: Chief Financial Officer | A-Award | 174,200 | $3.52 |
| Mar 11, 2025 | Schulz Fran · director | A-Award | 43,900 | $3.52 |
| Mar 11, 2025 | Mathers Edward T · director | A-Award | 43,900 | $3.52 |
| Mar 10, 2025 | Lu Timothy K · director, officer: CEO and Interim PFO and PAO | A-Award | 1,927,073 | $3.97 |
| Mar 10, 2025 | Lu Timothy K · director, officer: CEO and Interim PFO and PAO | A-Award | 642,358 | $0.00 |
| Mar 10, 2025 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | A-Award | 235,088 | $3.97 |
| Mar 10, 2025 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | A-Award | 78,363 | $0.00 |
| Feb 6, 2025 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | Sale | 182 | $4.37 |
| Feb 6, 2025 | Lu Timothy K · director, officer: CEO | Sale | 3,922 | $4.07 |
| Feb 6, 2025 | Lu Timothy K · director, officer: CEO | Sale | 545 | $4.36 |
| Feb 6, 2025 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | Sale | 1,297 | $4.07 |
| Dec 11, 2024 | BAYER HEALTHCARE LLC · 10 percent owner | Purchase | 3,333,000 | $2.30 |
| Dec 11, 2024 | BAYER HEALTHCARE LLC · 10 percent owner | Purchase | 2,222 | $0.00 |
| Dec 10, 2024 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | A-Award | 49,500 | $2.30 |
| Dec 10, 2024 | Rajangam Kanya · officer: Pres. & Chief Med. & Dev. Off. | A-Award | 33 | $2.25 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Mar 11, 2026